Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation

Marie A. Laryea, Kymberly D. Watt

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


The reinfection of the hepatic allograft with hepatitis B virus and hepatitis C virus can have important sequelae that result in poor long-term patient and graft survival. Although a response to treatment with antiviral medications can improve these outcomes, not all patients tolerate these medications or experience viral eradication. Avoiding reinfection of the graft is the most effective means of improving the long-term outcomes for these patient populations. This review is focused on the prevention of viral hepatitis reinfection after liver transplantation.

Original languageEnglish (US)
Pages (from-to)514-523
Number of pages10
JournalLiver Transplantation
Issue number5
StatePublished - May 2012

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation'. Together they form a unique fingerprint.

Cite this